Meeting
2015 ASCO Annual Meeting
Functional decline during first-line chemotherapy in elderly patients can be predicted by abnormal G8 score and performance status.
Authors
Camille Chakiba
Department of Medical Oncology, Institut Bergonié, Comprehensive Cancer Centre, Bordeaux, France
Camille Chakiba , Carine A. Bellera , Marianne Fonck , Jean-Frédéric Blanc , Joel Ceccaldi , Yves Imbert , Laurent Cany , Jérôme Dauba , Hugo Caillou , Simone Mathoulin-Pélissier , Muriel Rainfray , Pierre Soubeyran
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Patient and Survivor Care
Track
Patient and Survivor Care
Sub Track
Geriatric Oncology
Citation
J Clin Oncol 33, 2015 (suppl; abstr 9538)
DOI
10.1200/jco.2015.33.15_suppl.9538
Abstract #
9538
Poster Bd #
197
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Associations of frailty with overall survival (OS) and functional decline among older adults with non–small-cell lung cancer (NSCLC) receiving chemotherapy, immunotherapy, and/or targeted therapy.
First Author: Howard Jinsoo Lee Jr.
Poster
2019 Supportive Care in Oncology Symposium
Mixed methods comparison of functional decline during chemotherapy, immunotherapy (IO), and/or targeted therapy in older adults with non-small cell lung cancer (NSCLC).
First Author: Melisa L. Wong
Poster
2023 ASCO Annual Meeting
Older patients with early-stage triple-negative breast cancer: The Memorial Sloan Kettering Cancer Center experience.
First Author: Iris Zhi
Poster
2022 ASCO Annual Meeting
Remote geriatric assessment program for older patients starting new chemotherapy treatment in Brazil.
First Author: Cristiane Decat Bergerot